No Data
Express News | Bluebird Bio Shares Are Trading Lower After the FDA Announced an Investigation Into a Serious Risk of Hematologic Malignancy Following Skysona
FDA Investigating Safety Risks of Bluebird's Skysona
FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)
Spotless Brands Expands Into Idaho and Oregon With Acquisitions of Bluebird Express Car Wash and Epic Shine Car Wash
Wells Fargo Maintains Bluebird Bio(BLUE.US) With Hold Rating, Maintains Target Price $2
Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)
No Data
No Data
Jaguar8 : That is the really the accompanying risk of being ina clinical trial. This kind of adverse events is just troubling. I wonder how high their attrition rate is
Trytosaveabit OP Jaguar8 : Yeah I know! It just sux! You have a drug that really helps just to find out later it can add to the already bad situation! Grrr
Jaguar8 Trytosaveabit OP : True. Some subjects even die
Trytosaveabit OP Jaguar8 : Yup! My Mom was in a trial!
Jaguar8 Trytosaveabit OP : and what happened?
View more comments...